Psychological impact of von Hippel-Lindau genetic screening in patients with a previous history of hemangioblastoma of the central nervous system

Journal of Psychosocial Oncology
Claire RochetteDavid Taïeb

Abstract

Von Hippel-Lindau (VHL) syndrome is a hereditary cancer syndrome characterized by a high risk of developing benign and malignant tumors, including central nervous system hemangioblastomas (CNS HBs). For an early diagnosis of VHL, before the occurrence of cancers (especially renal cell carcinoma), it is of huge importance to initiate VHL genetic testing in at-risk patients. The aim of the study was to assess the psychological impact of VHL genetic testing in patients previously diagnosed with a CNS HB. From 1999 until 2015, 55 patients underwent surgery for CNS HBs. Eleven patients were already screened for VHL mutations and 3 patients deceased before the start of the study. From the remaining 42 patients, 24 were accepted to be enrolled in the study. Assessment of psychological impact of VHL genetic testing was performed by measuring anxiety levels, mood disorders, quality of life, and psychological consequences of genetic screening. Twenty-one of the enrolled 24 patients underwent VHL genetic testing and 12 patients came back for the communication of positive genetic results. The baseline psychological status did not differ between these 2 groups. Patients who attended the visit of communication of genetic results had similar ...Continue Reading

References

Nov 17, 1998·Journal of Clinical Epidemiology·A LeplègeT V Perneger
Apr 20, 2001·Journal of Neurology, Neurosurgery, and Psychiatry·S GläskerH P Neumann
Jun 1, 1961·Archives of General Psychiatry·A T BECKJ ERBAUGH
Oct 21, 2005·Journal of Nursing Scholarship : an Official Publication of Sigma Theta Tau International Honor Society of Nursing·Catherine Y ReadMary E Duffy
Jan 13, 2010·BMC Medical Genetics·Astrid RasmussenSanjay I Bidichandani
Feb 27, 2010·Clinical Genetics·C R M LammensN K Aaronson
Apr 20, 2010·Journal of Genetic Counseling·Aunchalee E L PalmquistEllen R Gritz
May 19, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Chantal R M LammensEveline M A Bleiker
Mar 3, 2012·The Breast : Official Journal of the European Society of Mastology·Nina BoschJudith Balmaña
May 15, 2013·Familial Cancer·Eveline M A BleikerAndrea Farkas Patenaude

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Clinical Trials Mentioned

NCT02120040

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.